Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures

Herzog, Charles A.; Jennie, Z.; Collins, Allan J.

doi:10.1161/01.cir.0000129317.12580.68

Cited by 89 publications

(62 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among patients with end-stage renal disease (ESRD), cardiac mortality is 10 to 30 times higher than in the general population. The mechanism of this association is not entirely known, but a higher prevalence of traditional risk factors in this population such as advanced age, hypertension and diabetes, contributes to accelerated atherosclerosis [2][3][4] .…”

Section: Introductionmentioning

confidence: 99%

Impacto da insuficiência renal crônica na eficácia de stents farmacológicos: estudo de seguimento de longo prazo

Gomes¹,

Blaya²,

Lasevitch³

et al. 2011

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Impacto da insuficiência renal crônica na eficácia de stents farmacológicos: estudo de seguimento de longo prazo

Gomes¹,

Blaya²,

Lasevitch³

et al. 2011

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

“…However, these data are limited by the retrospective design and the inherent risk of procedure-related referral bias based on coronary anatomy and patient characteristics. 145 An updated analysis of USRDS data from 2003 to 2005 by the same authors, including patients treated with DES, found superior 12-month unadjusted postprocedural survival in patients on dialysis who received DES (69.7%) compared with CABG (66.6%) or non-DES PCI (63.6%). 146 However, unadjusted 36-month survival favored CABG over DES (42.0% versus 38.1%), especially among patients who received an internal mammary artery bypass conduit.…”

Section: Lentine Et Al Cardiac Disease Evaluation and Management Amonmentioning

confidence: 99%

Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

Lentine¹,

Costa²,

Weir³

et al. 2012

Circulation

286

159

View full text Add to dashboard Cite

“…22 Recent reports from the BMS era showed comparable long-term survival after percutaneous and surgical coronary revascularization procedures in renal transplant recipients. 23 The invasiveness of CABG contributes to an increased risk of in-hospital death, postoperative mediastinitis and postoperative stroke. 24 After the approval of SES, a benefit of less invasive revascularization by PCI over CABG was expected.…”

Section: Mortality After Coronary Revascularization In Dialysis Patientsmentioning

confidence: 99%

One-Year Clinical Outcomes of Dialysis Patients After Implantation With Sirolimus-Eluting Coronary Stents

Okada

Hayashi

Toyofuku

et al. 2008

Circ J

View full text Add to dashboard Cite

ialysis patients show a complex morphology of coronary artery lesions, especially marked calcification, 1 and are at higher risk for target lesion revascularization (TLR) after coronary stenting than nondialysis patients. 2 Utilization of stenting and debulking techniques reportedly improves immediate and long-term outcomes after percutaneous coronary intervention (PCI) in patients with calcified and complex lesions. [2][3][4] Recently, the use of a sirolimus-eluting stent (SES; Cypher, Cordis, Johnson & Johnson, Miami Lakes, FL, USA) has been associated with a low restenosis rate 5,6 compared with bare-metal stents (BMS) in patients with de novo native coronary lesions of intermediate (10-30 mm) length. However, the efficacy of SES for calcified and complex lesions, such as those in dialysis patients, has not been confirmed. Moreover, when patients with heavily calcified lesions undergo coronary stenting, incomplete stent expansion may occur, leading to a risk of drug-eluting stent (DES) restenosis and thrombosis. 7 In a recent report, renal failure was identified as a predictor of thrombotic events after treatment with DES. 8 Little information about the safety and efficacy of SES for the treatment of coronary artery lesions in dialysis patients is available. The present study was undertaken to assess the intermediate-term outcomes of PCI using SES in dialysis patients. Methods Patient PopulationAmong consecutive patients who had undergone PCI with SES between August 2004 and September 2006, we identified an index cohort of 89 patients who had been on chronic dialysis before PCI in Tsuchiya General Hospital (Hiroshima, Japan). If a patient had a second or further PCI after the index PCI, only the first PCI was included in the creation of the index PCI cohort. Patients undergoing PCI for in-stent restenosis and patients with acute myocardial infarction (MI) were excluded. After exclusion of 6 patients with in-stent restenosis and 3 patients with acute MI, the remaining 80 patients treated with SES were compared with the historical group of consecutive 124 patients treated with BMS from April 2000 to July 2004. Patients treated with BMS diameter ≥4 mm or ≤2.25 mm were excluded because the equivalent sizes of SES were not approved in Japan. From August 2004 to September 2006, 12 dialysis patients were treated with BMS: 2 patients with anticipated major surgery, 2 patients with lesions in large vessels with no appropriate SES size available, 2 patients with acute MI, 2 patients who refused the treatment, and 4 patients in whom it was anticipated there would be difficulty in delivering the SES.We compared the 1-year clinical outcomes of patients treated with SES and BMS. Most subjects were residents of Hiroshima Prefecture, a genetically representative cohort of the Japanese population. The etiologies of renal failure in Cardiology, Akane-kai, Tsuchiya General Hospital, Hiroshima, Japan Mailing address: Mamoru Toyofuku, MD, Department of Cardiology, Akane-kai, Tsuchiya General Hospital, 3-30 Nakashima-cho, Nak...

show abstract

Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures

Abstract: Background-Retrospective studies in dialysis patients have reported increased survival after coronary artery bypass (CAB) compared with coronary artery stenting and PTCA.

Cited by 89 publications

References 20 publications

Impacto da insuficiência renal crônica na eficácia de stents farmacológicos: estudo de seguimento de longo prazo

Impacto da insuficiência renal crônica na eficácia de stents farmacológicos: estudo de seguimento de longo prazo

Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

One-Year Clinical Outcomes of Dialysis Patients After Implantation With Sirolimus-Eluting Coronary Stents

Contact Info

Product

Resources

About